This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

Text Version    RSS    Subscribe    Unsubscribe    Archive    Media Kit           April 30, 2014

Home     About SGO    Education    Membership    Clinical Practice    Public Policy    Blog    Partnerships    Store


ASTRO issues guideline recommendations for radiation therapy in endometrial cancer
HemOnc Today
The American Society for Radiation Oncology recently issued a new guideline, “The Role of Postoperative Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based Guideline,” that details the use of adjuvant radiation therapy in the treatment of endometrial cancer.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


HPV test for first-line cervical screen: Questions on use
Medscape (Free login required)
When the cobas HPV Test (Roche Molecular Systems) was approved for first-line screening of primary cervical cancer by the US Food and Drug Administration (FDA) last week, how and when it should be used was not addressed. The Society of Gynecologic Oncology (SGO) is working with the American Society for Colposcopy and Cervical Pathology (ASCCP) to produce interim guidelines on the use of the HPV test in first-line screening, but for now there are more questions than answers, and many opinions. Two experts told Medscape Medical News how they envisage its use.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

  ChemoFx Improves Ovarian Cancer Outcomes
ChemoFx® provides invaluable information to physicians choosing from 20+ equivalent treatment recommendations without prior knowledge of how individual patients may respond. ChemoFx determines platinum resistance in primary ovarian cancer and demonstrates longer overall survival by 14 months in recurrent ovarian cancer, making it instrumental in improving patient outcomes.


Multiple-gene sequencing IDs mutations in non-BRCA genes
HealthDay News via Doctors Lounge
A considerable number of women testing negative for BRCA1/2 may have pathogenic mutations in other genes, according to a study published online April 14 in the Journal of Clinical Oncology. "Our study demonstrates an early signal for the clinical relevance of multiple-gene sequencing and provides a strong rationale for future research to define its most effective use," the authors write.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Researchers identify mechanism of cancer caused by loss of BRCA1 and BRCA2 gene function
Medical Xpress
Investigators at Beth Israel Deaconess Medical Center (BIDMC) report a new mechanism by which BRCA gene loss may accelerate cancer-promoting chromosome rearrangements. The new findings, published online in the April 28 issue of Nature, explain how the loss of BRCA1 or BRCA2 function impairs homologous recombination (HR), a normally accurate repair process used to fix DNA breaks, and actually stimulates faulty error-prone HR repair.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Exceptional Care, Close to Home

21st Century Oncology – the nation’s largest cancer treatment network and global leader in cancer care – providing integrated clinical teams treating patients collaboratively to improve outcomes.
Lantheus Proven Success
Discovering, developing and marketing innovative medical imaging agents provides a strong platform from which to bring forward new breakthrough tools for the diagnosis and management of disease. MORE


Glow-in-dark surgery may help cancer patients
Operating in the dark would be challenging for most surgeons. But for Indiana University Health's Dr. Emma Rossi, a dimly lit room can be as critical as a scalpel. Rossi has been testing a new procedure to track the spread of gynecological cancers. She injects a fluorescent dye that glows in the dark into a patient and dims the lights in the operating room. Then she uses infrared imaging to track the path the cancer might have taken.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Researchers generate immunity against tumor vessel protein
Science Codex
A group of researchers from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania is pursuing this strategy by employing a novel DNA vaccine to kill cancer, not by attacking tumor cells, but targeting the blood vessels that keep them alive. The vaccine also indirectly creates an immune response to the tumor itself, amplifying the attack by a phenomenon called epitope spreading.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Imaging gives clearer picture of cancer drugs' chances of success
Medical Xpress
The quest for new cancer treatments could be revolutionized by advances in technology that can visualize living cells and tissues, scientists claim. Leading edge imaging techniques will make it easier to identify which are the most promising new drugs to take forward for patient testing, a review of the technology suggests. Applying such techniques early in the drug discovery process could improve the success rate of new medicines by helping to rule out drugs that are unlikely to work. Researchers are leading the way in using biological imaging to make the development of new cancer treatments more efficient.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


New approach may overcome breast cancer resistance to HER2-targeted therapies
Oncology Nurse Advisor
Resistance to a combination of human epidermal growth factor receptor 2 (HER2)-targeted therapies, trastuzumab and lapatinib, was associated with elevated activation of a group of proteins called fibroblast growth factor receptors (FGFRs), which are the target of a number of drugs currently being developed. These preclinical results were presented at the American Association for Cancer Research 2014 Annual Meeting, in San Diego, California.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Women's Cancer News
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Jessica Taylor, Senior Medical Editor, 202-684-7169  
Contribute news

Inclusion of advertisements does not constitute SGO endorsement of company products or services.

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the Women's Cancer News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

April 23, 2014
April 16, 2014
April 9, 2014
April 2, 2014

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063